JP2019214632A5 - - Google Patents

Download PDF

Info

Publication number
JP2019214632A5
JP2019214632A5 JP2019181618A JP2019181618A JP2019214632A5 JP 2019214632 A5 JP2019214632 A5 JP 2019214632A5 JP 2019181618 A JP2019181618 A JP 2019181618A JP 2019181618 A JP2019181618 A JP 2019181618A JP 2019214632 A5 JP2019214632 A5 JP 2019214632A5
Authority
JP
Japan
Prior art keywords
composition
hyaluronan
concentration
elasticity
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019181618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019214632A (ja
JP7025039B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019214632A publication Critical patent/JP2019214632A/ja
Publication of JP2019214632A5 publication Critical patent/JP2019214632A5/ja
Priority to JP2022015509A priority Critical patent/JP2022058871A/ja
Application granted granted Critical
Publication of JP7025039B2 publication Critical patent/JP7025039B2/ja
Priority to JP2024010878A priority patent/JP2024028669A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019181618A 2013-07-10 2019-10-01 高い弾性を有するヒアルロナンの組成物およびその使用 Active JP7025039B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022015509A JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361844645P 2013-07-10 2013-07-10
US61/844,645 2013-07-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018114766A Division JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022015509A Division JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2019214632A JP2019214632A (ja) 2019-12-19
JP2019214632A5 true JP2019214632A5 (enExample) 2020-02-06
JP7025039B2 JP7025039B2 (ja) 2022-02-24

Family

ID=51261252

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016525455A Active JP6357228B2 (ja) 2013-07-10 2014-07-09 高い弾性を有するヒアルロナンの組成物およびその使用
JP2018114766A Active JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用
JP2019181618A Active JP7025039B2 (ja) 2013-07-10 2019-10-01 高い弾性を有するヒアルロナンの組成物およびその使用
JP2022015509A Withdrawn JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A Pending JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016525455A Active JP6357228B2 (ja) 2013-07-10 2014-07-09 高い弾性を有するヒアルロナンの組成物およびその使用
JP2018114766A Active JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022015509A Withdrawn JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A Pending JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Country Status (8)

Country Link
US (5) US9492474B2 (enExample)
EP (3) EP4137139A1 (enExample)
JP (5) JP6357228B2 (enExample)
AR (2) AR096875A1 (enExample)
ES (2) ES2933549T3 (enExample)
PL (2) PL3613423T3 (enExample)
PT (2) PT3019177T (enExample)
WO (1) WO2015006460A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137139A1 (en) 2013-07-10 2023-02-22 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
ES2871199T3 (es) 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
WO2020144372A1 (en) 2019-01-10 2020-07-16 The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin Composite viscoelastic hydrogel, and uses thereof for sealing a channel in tissue
ES2976202T3 (es) 2018-01-10 2024-07-26 The Provost Fellows Scholars And Other Members Of Board Of Trinity College Dublin Sistema para sellar un canal en tejido
EP3781175A1 (en) 2018-04-18 2021-02-24 i.com Medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
EP3969057B1 (en) * 2019-05-17 2025-12-17 The Governing Council of the University of Toronto Sustained release local anesthetic hydrogel composition

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
IN163192B (enExample) 1983-10-11 1988-08-20 Fidia Spa
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
AU620821B2 (en) 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
EP0414373B2 (en) * 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stable solution of hyaluronate in a balanced salt medium
AU652022B2 (en) 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
AU682670B2 (en) 1993-02-05 1997-10-16 Becton Dickinson & Company Syringe needle isolation device
US5624915A (en) 1993-08-04 1997-04-29 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5607400A (en) 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
IT1277707B1 (it) 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
JPH09173450A (ja) 1995-12-26 1997-07-08 Nissho Corp プレフィルドシリンジ
JP3293122B2 (ja) 1996-12-13 2002-06-17 ニプロ株式会社 プレフィルドシリンジ
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
RU2126669C1 (ru) 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения синдрома сухого глаза
SE9703425D0 (sv) 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
DE19751219A1 (de) 1997-11-19 1999-05-27 Vetter & Co Apotheker Spritze, insbesondere vorgefüllte Spritze, oder Karpule
JP4216467B2 (ja) 1998-03-13 2009-01-28 ベクトン・ディキンソン・アンド・カンパニー 医療装置の組立ておよび包装方法
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
JP3591636B2 (ja) 2000-04-03 2004-11-24 ニプロ株式会社 プレフィルドシリンジ
DE60100866T2 (de) 2000-04-07 2004-07-29 Laboratoire Medidom S.A. Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
US7635489B2 (en) 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
JP2003119147A (ja) * 2001-10-10 2003-04-23 Raku:Kk ヒアルロン酸化合物の水溶液組成物
ATE547122T1 (de) 2001-11-21 2012-03-15 Novartis Pharma Gmbh Zusammensetzung zur stabilisierung von hyaluronsäure
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
US7081107B2 (en) 2002-07-02 2006-07-25 Terumo Kabushiki Kaisha Syringe and prefilled syringe
RU2005102604A (ru) 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
WO2004028536A1 (en) 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
DE10254321A1 (de) 2002-11-21 2004-06-17 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze
JP2004229750A (ja) 2003-01-28 2004-08-19 Nipro Corp プレフィルドシリンジ及びそのバレルの製造方法
US20040167480A1 (en) 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
JP2004262777A (ja) 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US20050075611A1 (en) 2003-10-01 2005-04-07 Hetzler Kevin G. Low extractable, thermoplastic syringe and tip cap
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US7544671B2 (en) 2004-05-07 2009-06-09 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
WO2006067608A1 (en) 2004-12-22 2006-06-29 Laboratoire Medidom S.A. Aqueous formulations based on sodium hyaluronate for parenteral use
EP2664334B1 (en) * 2004-12-30 2015-03-04 Genzyme Corporation Regimens for intra-articular viscosupplementation
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
US7767710B2 (en) 2005-05-25 2010-08-03 Calosyn Pharma, Inc. Method for treating osteoarthritis
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
WO2007059890A1 (en) * 2005-11-22 2007-05-31 Centre National De Recherche Scientifique New derivatives of hyaluronic acid, their preparation process and their uses
US7988675B2 (en) 2005-12-08 2011-08-02 West Pharmaceutical Services Of Delaware, Inc. Automatic injection and retraction devices for use with pre-filled syringe cartridges
EP1968614A2 (en) 2005-12-14 2008-09-17 Anika Therapeutics Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
JP4682850B2 (ja) 2006-01-12 2011-05-11 ニプロ株式会社 プレフィルドシリンジ
US20070254841A1 (en) 2006-01-25 2007-11-01 Ophthalmic Research Associates, Inc. Formulations and methods for treating dry eye
US7674781B2 (en) 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
AR062046A1 (es) 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
BRPI0716270A2 (pt) 2006-08-28 2013-08-13 Rexaderm Inc bandagem de ferida seca e sistema de distribuiÇço de fÁrmaco
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
AU2007320123A1 (en) 2006-11-17 2008-05-22 Agency For Science, Technology And Research Porous polymeric material with cross-linkable wetting agent
CN101389342B (zh) 2006-12-05 2012-08-08 株式会社糖质科学研究所 用于变性关节炎的治疗剂
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
WO2009111159A2 (en) 2008-03-03 2009-09-11 New York University Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
WO2009122541A1 (ja) * 2008-03-31 2009-10-08 Inui Hiroaki ヒト胚の体外受精及び培養用培養液及びヒト胚の体外受精及び培養方法
JP5758797B2 (ja) 2008-04-04 2015-08-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
AU2010204445B2 (en) * 2009-01-07 2015-09-03 2405871 Ontario Inc. Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
US20100178317A1 (en) 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US8979821B2 (en) 2009-04-14 2015-03-17 Fezza Family Properties, Llc Lacrimal filler
US20100303915A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Therapeutic opthalmic emulsions
US20120128754A1 (en) 2009-06-05 2012-05-24 Edward Tak Wei Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
US8673340B2 (en) 2009-09-10 2014-03-18 Boston Foundation For Sight Sodium channel blocker delivery system with scleral lens
US20120264689A1 (en) 2009-10-07 2012-10-18 Genogen, Inc. Methods and compositions for skin regeneration
US20110171310A1 (en) 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
HUE030138T2 (en) 2010-03-22 2017-04-28 Allergan Inc Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US20130209531A1 (en) 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
WO2012027834A1 (en) 2010-09-02 2012-03-08 Mcmaster University Hyaluronic acid-containing biopolymers
WO2012033189A1 (ja) 2010-09-10 2012-03-15 参天製薬株式会社 Ｐ２ｙ2受容体作動薬およびヒアルロン酸またはその塩を組み合わせたことを特徴とするドライアイ治療剤、ドライアイの治療方法、ならびにその使用
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US20140038917A1 (en) * 2011-04-19 2014-02-06 Anteis S.A. Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
GB201118586D0 (en) 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
RS53135B (sr) 2011-11-24 2014-06-30 Quimera Ingenieria Biomedica, S.L. Kompleks dobijen iz hijaluronske kiseline ili njene soli i smeša hondroitin sulfata
US20150037422A1 (en) 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
US20150018305A1 (en) 2012-02-22 2015-01-15 Hyaluronan Research Institute, Inc. Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active ingredient
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
LT2950783T (lt) 2013-02-01 2019-10-25 Allergan Inc Dirbtinės ašaros, kurių sudėtyje yra natrio hialuronato ir karboksimetilceliuliozės
US9226938B2 (en) 2013-03-14 2016-01-05 RMG Rehabilitation Management Group, LP Combinatorial therapy for treatment of osteoarthritis of the knee
EP2979539B1 (en) 2013-03-25 2017-12-20 National University Corporation Tokyo University Of Agriculture and Technology Plant cultivation method
ITMI20130883A1 (it) 2013-05-30 2014-12-01 Eurores S R L Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
EP4137139A1 (en) 2013-07-10 2023-02-22 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
ES2784229T3 (es) 2013-11-20 2020-09-23 Panag Pharma Inc Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular
US9187576B2 (en) 2013-11-25 2015-11-17 Deuteria Biomaterials, Llc Deuterium-enriched hyaluronan
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
ES2871199T3 (es) 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas

Similar Documents

Publication Publication Date Title
JP2006516032A5 (enExample)
Rubin Mucolytics, expectorants, and mucokinetic medications
Tavassoly et al. Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection
Henke et al. Mucolytics in cystic fibrosis
Irvin et al. Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain
Clunes et al. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
Tiwari et al. Role of heparan sulfate in sexually transmitted infections
JP5785085B2 (ja) 癒着を処置又は防止するためのポリペプチド
EP1982723A1 (en) Immobilisation and stabilisation of virus
JP2018525423A5 (enExample)
KR20200136980A (ko) 리신-항미생물 펩타이드(amp) 폴리펩타이드 작제물, 리신, 이를 인코딩하는 단리된 폴리뉴클레오타이드 및 이의 용도
JP2003534036A (ja) 中耳手術における使用のための粘弾剤
JP2013543862A5 (enExample)
TW201718028A (zh) Ve-鈣黏蛋白結合性生物結合物
KR20090060348A (ko) 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
Nagl et al. N-chlorotaurine, a promising future candidate for topical therapy of fungal infections
JP2021533728A (ja) 溶解素−抗微生物ペプチド（ａｍｐ）ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
Teh et al. Aspergillus sinusitis in patients with AIDS: report of three cases and review
Contini et al. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application
CY1111939T1 (el) Φαρμακευτικο στερεο παρασκευασμα που περιλαμβανει βενζαζεπινες και μεθοδος παρασκευης αυτου
KR20190072579A (ko) 폴리믹신-알기네이트 올리고머 콘주게이트
WO2016065083A1 (en) Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
JP2022530837A5 (enExample)
Hafez et al. Activity of some mucolytics against bacterial adherence to mammalian cells
WO2017060550A1 (es) Una composición farmacéutica bactericida y virucida